Annual Total Liabilities
$107.12 M
+$48.42 M+82.47%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual total liabilities is $107.12 million, with the most recent change of +$48.42 million (+82.47%) on December 31, 2024.
- During the last 3 years, NAMS annual total liabilities has risen by +$95.81 million (+846.96%).
- NAMS annual total liabilities is now at all-time high.
Performance
NAMS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$107.12 M
+$46.79 M+77.56%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly total liabilities is $107.12 million, with the most recent change of +$46.79 million (+77.56%) on December 31, 2024.
- Over the past year, NAMS quarterly total liabilities has increased by +$46.79 million (+77.56%).
- NAMS quarterly total liabilities is now at all-time high.
Performance
NAMS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NAMS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.5% | +77.6% |
| 3 y3 years | +847.0% | +77.6% |
| 5 y5 years | +580.0% | +77.6% |
NAMS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +847.0% | at high | +847.0% |
| 5 y | 5-year | at high | +847.0% | at high | +847.0% |
| alltime | all time | at high | +847.0% | at high | +847.0% |
NewAmsterdam Pharma Company NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $107.12 M(+82.5%) | $107.12 M(+77.6%) |
| Sep 2024 | - | $60.33 M(+1.8%) |
| Jun 2024 | - | $59.25 M(-22.7%) |
| Mar 2024 | - | $76.66 M(+30.6%) |
| Dec 2023 | $58.70 M | $58.70 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $53.07 M(+9.6%) |
| Dec 2022 | $48.43 M(+328.1%) | $48.43 M(+38.7%) |
| Jun 2022 | - | $34.92 M(+208.7%) |
| Dec 2021 | $11.31 M(-28.2%) | $11.31 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total liabilities?
- What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual total liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly total liabilities year-on-year change?
What is NewAmsterdam Pharma Company NV annual total liabilities?
The current annual total liabilities of NAMS is $107.12 M
What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total liabilities is $107.12 M
What is NewAmsterdam Pharma Company NV annual total liabilities year-on-year change?
Over the past year, NAMS annual total liabilities has changed by +$48.42 M (+82.47%)
What is NewAmsterdam Pharma Company NV quarterly total liabilities?
The current quarterly total liabilities of NAMS is $107.12 M
What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total liabilities is $107.12 M
What is NewAmsterdam Pharma Company NV quarterly total liabilities year-on-year change?
Over the past year, NAMS quarterly total liabilities has changed by +$46.79 M (+77.56%)